Immune cells in colon tumors could hold key to predicting recurrence risk
NCT ID NCT02557061
First seen Apr 28, 2026 · Last updated May 04, 2026 · Updated 1 time
Summary
This study looked at 56 people who had surgery for colon cancer that had not spread. Researchers wanted to see if the number and type of immune cells inside the tumor could help predict which patients might have a recurrence. They analyzed blood samples and tumor tissue to understand the immune response better, aiming to improve future treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rouen University Hospital
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.